{"news_desk": "SundayBusiness", "print_page": "7", "section_name": "Your Money", "subsection_name": null, "byline": {"original": "By JEFF SOMMER", "person": [{"rank": 1, "role": "reported", "firstname": "Jeff", "organization": "", "lastname": "SOMMER"}]}, "abstract": "Jeff Sommer Strategies column asserts investors believe government will obstruct tax inversion merger of Allergan and Pfizer; public and politicians have been calling for end to such mergers. ", "type_of_material": "News", "word_count": "1217", "lead_paragraph": "A spread in share prices suggests that the drug maker\u2019s tax inversion deal with Allergan may not yet be in the bag.", "pub_date": "2016-03-13T00:00:00Z", "document_type": "article", "slideshow_credits": null, "headline": {"main": "Pfizer\u2019s Eager to Go, but the Market Has Doubts", "content_kicker": "Strategies", "print_headline": "Pfizer\u2019s Eager to Go, but the Market Has Doubts", "kicker": "Strategies"}, "snippet": "A spread in share prices suggests that the drug maker\u2019s tax inversion deal with Allergan may not yet be in the bag.", "multimedia": [{"height": 126, "url": "images/2016/03/13/business/13STRA/13STRA-thumbWide.jpg", "legacy": {"widewidth": "190", "wideheight": "126", "wide": "images/2016/03/13/business/13STRA/13STRA-thumbWide.jpg"}, "type": "image", "width": 190, "subtype": "wide"}, {"height": 375, "url": "images/2016/03/13/business/13STRA/13STRA-articleLarge.jpg", "legacy": {"xlargewidth": "600", "xlargeheight": "375", "xlarge": "images/2016/03/13/business/13STRA/13STRA-articleLarge.jpg"}, "type": "image", "width": 600, "subtype": "xlarge"}, {"height": 75, "url": "images/2016/03/13/business/13STRA/13STRA-thumbStandard.jpg", "legacy": {"thumbnailwidth": "75", "thumbnail": "images/2016/03/13/business/13STRA/13STRA-thumbStandard.jpg", "thumbnailheight": "75"}, "type": "image", "width": 75, "subtype": "thumbnail"}], "web_url": "http://www.nytimes.com/2016/03/13/your-money/pfizers-eager-to-go-but-the-market-has-doubts.html", "keywords": [{"rank": "1", "is_major": "Y", "value": "Allergan Inc", "name": "organizations"}, {"rank": "2", "is_major": "Y", "value": "Pfizer Inc", "name": "organizations"}, {"rank": "3", "is_major": "Y", "value": "Corporate Taxes", "name": "subject"}, {"rank": "4", "is_major": "N", "value": "Taxation", "name": "subject"}, {"rank": "5", "is_major": "N", "value": "Mergers, Acquisitions and Divestitures", "name": "subject"}, {"rank": "6", "is_major": "N", "value": "Treasury Department", "name": "organizations"}, {"rank": "7", "is_major": "N", "value": "Tax Shelters", "name": "subject"}], "blog": [], "_id": "56e4634038f0d83a21f5bde6", "source": "The New York Times"}